Abstract:Double‐stranded DNA nanostructures fully inhibit amyloid fibril formation and efficiently disassemble enzymatically and thermodynamically stable fibrils into cytocompatible and degradable complexes. Remarkably, DNA nanostructures avidly trap highly toxic soluble oligomeric species in complex biological media and convert them into non‐toxic binary complexes. The deposition of insoluble proteinaceous aggregates in the form of amyloid fibrils within the extracellular space of tissues is associated with numerous diseases. The development of molecular approaches to arrest amyloid formation and prevent cellular degeneration remains very challenging due to the complexity of the process of protein aggregation, which encompasses an infinite array of conformations and quaternary structures. Polyanionic biopolymers, such as glycosaminoglycans and RNAs, have been shown to modulate the self‐assembly of amyloidogenic polypeptides and to reduce the toxicity induced by the formation of oligomeric and/or pre‐fibrillar proteospecies. This study evaluates the effects of double‐stranded DNA (dsDNA) nanostructures (1D, 2D, and 3D) on amyloid self‐assembly, fibril disaggregation, and the cytotoxicity associated with amyloidogenesis. Using the islet amyloid polypeptide (IAPP) whose pancreatic accumulation is the hallmark of type 2 diabetes, it was observed that dsDNA nanostructures inhibit amyloid formation by inducing the formation of spherical complexes in which the peptide adopts a random coil conformation. Interestingly, the DNA nanostructures showed a persistent ability to disassemble enzymatically and thermodynamically stable amyloid fibrils into nanoscale DNA/IAPP entities that are fully compatible with β‐pancreatic cells and are biodegradable by proteolysis. Notably, dsDNA nanostructures avidly trapped highly toxic soluble oligomeric species in complete cell culture media and converted them into non‐toxic binary complexes. Overall, these results expose the potent modulatory effects of dsDNA on amyloidogenic pathways, and these DNA nanoscaffolds could be used as a source of inspiration for the design of molecules to fight amyloid‐related disorders.

Supramolecular Detoxification of Neurotoxic Nanofibrils of Small Molecules Via Morphological Switch.

Molecular Simulations of Amyloid Structures, Toxicity, and Inhibition

A Supramolecular Protein Assembly Intrinsically Rescues Memory Deficits in an Alzheimer’s Disease Mouse Model

Drug-based Magnetic Imprinted Nanoparticles: Enhanced Lysozyme Amyloid Fibrils Cleansing and Anti-Amyloid Fibrils Toxicity

Nanocomposites Inhibit the Formation, Mitigate the Neurotoxicity, and Facilitate the Removal of Β-Amyloid Aggregates in Alzheimer’s Disease Mice

Supramolecular Nanofibrils Inhibit Cancer Progression in Vitro and in Vivo

Α-Helical Motif As Inhibitors of Toxic Amyloid-β Oligomer Generation Via Highly Specific Recognition of Amyloid Surface

Attenuation of the Aggregation and Neurotoxicity of Amyloid Peptides with Neurotransmitter-Functionalized Ultra-Small-Sized Gold Nanoparticles

Neuroprotective Nanoscavenger Induces Coaggregation of Β-Amyloid and Facilitates Its Clearance in Alzheimer’s Disease Brain

Small Molecule-Mediated Co-Assembly of Amyloid-Β Oligomers Reduces Neurotoxicity Through Promoting Non-Fibrillar Aggregation.

Turning the structure of the A beta(42) peptide by different functionalized carbon nanotubes: a molecular dynamics simulation study

Isomeric Effect of Nano-Inhibitors on Aβ40 Fibrillation at The Nano-Bio Interface

Charged Tubular Supramolecule Boosting Multivalent Interactions for the Drastic Suppression of Aβ Fibrillation

Nanocomposites Facilitate the Removal of Aβ Fibrils for Neuroprotection

Observation of reduced cytotoxicity of aggregated amyloidogenic peptides with chaperone-like molecules.

Molecular Mechanism of Cyanidin-3-O-Glucoside Disassembling Aβ Fibril in Silico

Studies of the Interaction Between Aβ Peptides and Carbon Nano-Materials

Self‐Destructive Nanoscavengers Capture and Clear Neurotoxic Soluble β‐Amyloid Aggregates

Designed peptides as nanomolar cross-amyloid inhibitors acting via supramolecular nanofiber co-assembly

DNA nanostructures prevent the formation of and convert toxic amyloid proteospecies into cytocompatible and biodegradable spherical complexes

Revealing the Mechanism of Amyloid Fibril Formation by Combined Single Molecule FRET and Kinetic Modeling